Trejtnar F - Search Results

1

99mTc demotate 1: biodistribution and elimination characteristics in rats.

Kopecky M, Trejtnar F, Laznicek M, Laznickova A, Semecky V, Maina T, Nock B. Kopecky M, et al. Among authors: trejtnar f. Nucl Med Commun. 2005 Jun;26(6):549-54. doi: 10.1097/00006231-200506000-00011. Nucl Med Commun. 2005. PMID: 15891599

2

Possible use of excretion of tubular epithelial cells for the study of the nephrotoxic effect of xenobiotics.

Stĕtinová V, Trejtnar F, Kopecký J, Grossmann V, Kvètina J, Kopecká L, Semecký V. Stĕtinová V, et al. Among authors: trejtnar f. J Pharmacol Toxicol Methods. 1996 Dec;36(4):199-204. doi: 10.1016/s1056-8719(96)00126-8. J Pharmacol Toxicol Methods. 1996. PMID: 9040110

3

Pharmacokinetics and renal handling of 99mTc-labeled peptides.

Trejtnar F, Laznicek M, Laznickova A, Mather SJ. Trejtnar F, et al. J Nucl Med. 2000 Jan;41(1):177-82. J Nucl Med. 2000. PMID: 10647621 Free article.

4

Distribution and elimination characteristics of 111In-DTPA-D-phe1-octreotide and 111In-DTPA-L-phe1-octreotide in rats.

Laznickova A, Laznicek M, Trejtnar F, Melicharova L, Suzuki KH, Akizawa H, Arano Y, Yokoyama A. Laznickova A, et al. Among authors: trejtnar f. Eur J Drug Metab Pharmacokinet. 2002 Jan-Mar;27(1):37-43. doi: 10.1007/BF03190403. Eur J Drug Metab Pharmacokinet. 2002. PMID: 11996325

5

Analysis of renal handling of radiopharmaceuticals.

Trejtnar F, Laznicek M. Trejtnar F, et al. Q J Nucl Med. 2002 Sep;46(3):181-94. Q J Nucl Med. 2002. PMID: 12134135 Review.

6

Lanreotide labeled with 99mTc: preparation, preclinical testing and comparison with (111)In-DTPA-octreotide.

Laznicek M, Laznickova A, Trejtnar F, Lorenc P, Varvarigou A, Bouziotis P, Archimandritis S. Laznicek M, et al. Among authors: trejtnar f. Anticancer Res. 2002 Jul-Aug;22(4):2125-30. Anticancer Res. 2002. PMID: 12174893

7

Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.

Trejtnar F, Laznicek M, Laznickova A. Trejtnar F, et al. Nucl Med Biol. 2003 Jan;30(1):45-9. doi: 10.1016/s0969-8051(02)00377-3. Nucl Med Biol. 2003. PMID: 12493542

8

Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.

Kopecky M, Semecky V, Trejtnar F, Laznicek M, Laznickova A, Nachtigal P, Decristoforo C, Mather SJ, Mäcke HR. Kopecky M, et al. Among authors: trejtnar f. Nucl Med Biol. 2004 Feb;31(2):231-9. doi: 10.1016/j.nucmedbio.2003.06.001. Nucl Med Biol. 2004. PMID: 15013489

9

Biodistribution and elimination characteristics of two 111In-labeled CCK-2/gastrin receptor-specific peptides in rats.

Trejtnar F, Laznicek M, Laznickova A, Kopecky M, Petrik M, Béhé M, Schmidt J, Maecke H, Maina T, Nock B. Trejtnar F, et al. Anticancer Res. 2007 Mar-Apr;27(2):907-12. Anticancer Res. 2007. PMID: 17465219 Free article.

10

In vitro comparison of renal handling and uptake of two somatostatin receptor-specific peptides labeled with indium-111.

Trejtnar F, Novy Z, Petrik M, Laznickova A, Melicharova L, Vankova M, Laznicek M. Trejtnar F, et al. Ann Nucl Med. 2008 Dec;22(10):859-67. doi: 10.1007/s12149-008-0192-6. Epub 2009 Jan 8. Ann Nucl Med. 2008. PMID: 19142704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters